University of Washington Medical Center BL2267075U-017

PYL-C RADIOPHARMACEUTICAL

The University of Washington Medical Center, a public hospital in Washington state, awarded a contract on June 9, 2022, to Progenics Pharmaceuticals Inc. for the supply of PYL-C Radiopharmaceuticals. The total obligated amount is $156,050. The purchase includes three line items: 99 units at $4,738 each, 35 units at $4,600 each, and a negative quantity of 134 units at $3,537.4 each, indicating a return or adjustment. The award is a single-transaction procurement for medical radiopharmaceuticals, with no indication of a multi-year or blanket arrangement. The award is categorized under the 'public_hospital' buyer, which corresponds to the 'local' category, and is located in Seattle, Washington, USA. The awardee, Progenics Pharmaceuticals Inc., is a pharmaceutical company specializing in radiopharmaceuticals. The procurement likely involved a competitive process, but specific competitors are not listed.

Description

PYL-C RADIOPHARMACEUTICAL